148 related articles for article (PubMed ID: 17337750)
1. Trends in economic consequences of rheumatoid arthritis over two subsequent years.
Verstappen SM; Jacobs JW; Kruize AA; Ehrlich JC; van Albada-Kuipers GA; Verkleij H; Buskens E; Bijlsma JW
Rheumatology (Oxford); 2007 Jun; 46(6):968-74. PubMed ID: 17337750
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project).
Hallert E; Husberg M; Jonsson D; Skogh T
Rheumatology (Oxford); 2004 Nov; 43(11):1374-82. PubMed ID: 15280570
[TBL] [Abstract][Full Text] [Related]
3. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
[TBL] [Abstract][Full Text] [Related]
4. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.
Michaud K; Messer J; Choi HK; Wolfe F
Arthritis Rheum; 2003 Oct; 48(10):2750-62. PubMed ID: 14558079
[TBL] [Abstract][Full Text] [Related]
5. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.
Clarke AE; St-Pierre Y; Joseph L; Penrod J; Sibley JT; Haga M; Genant HK
J Rheumatol; 2001 Nov; 28(11):2416-24. PubMed ID: 11708412
[TBL] [Abstract][Full Text] [Related]
6. Determinants of direct costs in Dutch rheumatoid arthritis patients.
Verstappen SM; Verkleij H; Bijlsma JW; Buskens E; Kruize AA; Heurkens AH; Van Der Veen MJ; Jacobs JW
Ann Rheum Dis; 2004 Jul; 63(7):817-24. PubMed ID: 15194577
[TBL] [Abstract][Full Text] [Related]
7. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists?
Gabriel SE; Wagner JL; Zinsmeister AR; Scott CG; Luthra HS
Arthritis Rheum; 2001 Jul; 44(7):1504-14. PubMed ID: 11465700
[TBL] [Abstract][Full Text] [Related]
8. Costs of rheumatoid arthritis in France: a multicenter study of 1109 patients managed by hospital-based rheumatologists.
Guillemin F; Durieux S; Daurès JP; Lafuma A; Saraux A; Sibilia J; Bourgeois P; Sany J
J Rheumatol; 2004 Jul; 31(7):1297-304. PubMed ID: 15229947
[TBL] [Abstract][Full Text] [Related]
9. Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study.
Lajas C; Abasolo L; Bellajdel B; Hernández-García C; Carmona L; Vargas E; Lázaro P; Jover JA
Arthritis Rheum; 2003 Feb; 49(1):64-70. PubMed ID: 12579595
[TBL] [Abstract][Full Text] [Related]
10. What are the costs to society and the potential benefits from the effective management of early rheumatoid arthritis?
March L; Lapsley H
Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):171-85. PubMed ID: 11358421
[TBL] [Abstract][Full Text] [Related]
11. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
Merkesdal S; Ruof J; Huelsemann JL; Mittendorf T; Handelmann S; Mau W; Zeidler H
Arthritis Rheum; 2005 Apr; 53(2):234-40. PubMed ID: 15818718
[TBL] [Abstract][Full Text] [Related]
12. [Approximation to the cost of pharmacological treatment of rheumatoid arthritis in Spain].
Mera Varela A; Blanco Rodríguez J; Caamaño Freire M
An Med Interna; 2003 Mar; 20(3):114-21. PubMed ID: 12756895
[TBL] [Abstract][Full Text] [Related]
13. Predicting the short term direct medical costs incurred by patients with rheumatoid arthritis.
Clarke AE; Levinton C; Joseph L; Penrod J; Zowall H; Sibley JT; Grover SA; Esdaile JM
J Rheumatol; 1999 May; 26(5):1068-75. PubMed ID: 10332970
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and economic burden of illness in very early arthritis. A population based study in southern Sweden.
Söderlin MK; Kautiainen H; Skogh T; Leirisalo-Repo M
J Rheumatol; 2004 Sep; 31(9):1717-22. PubMed ID: 15338489
[TBL] [Abstract][Full Text] [Related]
15. Work disability in rheumatoid arthritis 10 years after the diagnosis.
Sokka T; Kautiainen H; Möttönen T; Hannonen P
J Rheumatol; 1999 Aug; 26(8):1681-5. PubMed ID: 10451062
[TBL] [Abstract][Full Text] [Related]
16. Markers for work disability in rheumatoid arthritis.
Sokka T; Pincus T
J Rheumatol; 2001 Jul; 28(7):1718-22. PubMed ID: 11469487
[TBL] [Abstract][Full Text] [Related]
17. Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity.
Verstappen SM; Boonen A; Verkleij H; Bijlsma JW; Buskens E; Jacobs JW;
Ann Rheum Dis; 2005 Dec; 64(12):1754-60. PubMed ID: 15860510
[TBL] [Abstract][Full Text] [Related]
18. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996.
Ward MM; Fries JF
J Rheumatol; 1998 Mar; 25(3):408-16. PubMed ID: 9517756
[TBL] [Abstract][Full Text] [Related]
19. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study.
Clarke AE; Zowall H; Levinton C; Assimakopoulos H; Sibley JT; Haga M; Shiroky J; Neville C; Lubeck DP; Grover SA; Esdaile JM
J Rheumatol; 1997 Jun; 24(6):1051-60. PubMed ID: 9195508
[TBL] [Abstract][Full Text] [Related]
20. Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
Newhall-Perry K; Law NJ; Ramos B; Sterz M; Wong WK; Bulpitt KJ; Park G; Lee M; Clements P; Paulus HE
J Rheumatol; 2000 May; 27(5):1156-63. PubMed ID: 10813281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
